Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2CNS 2Lymphoid 1

Conditions

Lymphoma 272Lymphoma, Large B-Cell, Diffuse 259Leukemia, Lymphocytic, Chronic, B-Cell 189Lymphoma, Non-Hodgkin 187Lymphoma, Mantle-Cell 165Lymphoma, Follicular 164Lymphoma, B-Cell, Marginal Zone 115Leukemia 94Burkitt Lymphoma 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Waldenstrom Macroglobulinemia 77Lymphoma, B-Cell 62Recurrence 51Hodgkin Disease 50Lymphoma, Large-Cell, Immunoblastic 44Lymphoma, Large-Cell, Anaplastic 20Leukemia, Myeloid, Acute 20Myelodysplastic Syndromes 18Intraocular Lymphoma 15Hematologic Neoplasms 15Neoplasms 14Dendritic Cell Sarcoma, Interdigitating 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Multiple Myeloma 13Leukemia, Hairy Cell 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Neoplasms, Plasma Cell 10Leukemia, Prolymphocytic 10Lymphoma, T-Cell 9Leukemia, Myelomonocytic, Chronic 9

Interventions

Pemetrexed 18Bevacizumab 9Spinal Puncture 7Radiotherapy 7Specimen Handling 5Methotrexate 5Magnetic Resonance Spectroscopy 5osimertinib 4aflutinib 4Trastuzumab 3Topotecan 3Temozolomide 3Dexamethasone 3trastuzumab deruxtecan 2pembrolizumab 2merphos 2lorlatinib 2Vitamin B 12 2Rituximab 2Radiotherapy, Intensity-Modulated 2Folic Acid 2Drug Therapy 2Cytarabine 2Cyclophosphamide 2tucatinib 1toripalimab 1sintilimab 1sacituzumab govitecan 1pertuzumab 1peginterferon alfa-2b 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Meningeal Carcinomatosis × Rituximab × Clear all
NCT01596127 2018-05-24

Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System

M.D. Anderson Cancer Center

Phase 1/2 Terminated
4 enrolled 7 charts
CNSOther hematologic neoplasm

Central Nervous System Diseases, Leukemia, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT00416923 2015-02-16

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

University of California, San Francisco

Phase 1 Completed
10 enrolled
CNSLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Meningeal Carcinomatosis, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡